Bevacizumab [Cas No. 216974-75-3]
Catalog No：TA-T9904
Manufacturer：TargetMol
CAS No.：216974-75-3
MWt：149 kDa
€174,00 – €2.248,00
| Name: | Bevacizumab |
| Category: | Biochemicals |
| Description: | Ipilimumab anti-CTLA-4) is an immunomodulatory monoclonal antibody directed against the cell surface antigen CTLA-4 and also a type of immune checkpoint inhibitor.Bevacizumab a humanized monoclonal antibody specifically binds to all VEGF-A isoforms with high affinity. |
| Pathway: | 0 |
| Target: | VEGF |
| Receptor: | 0 |
Help & Support
Product
Guarantee and
Expert Support
Related products
Catalog No：TA-PDK0101
Manufacturer：TargetMol
CAS No.：1866-39-3
Formula：C10H10O2
MWt：162.19
€29,00 – €50,00
Catalog No：TA-PDK0014
Manufacturer：TargetMol
CAS No.：1076-22-8
Formula：C6H6N4O2
MWt：166.1
€47,00 – €112,00
Catalog No：TA-Fr16745
Manufacturer：TargetMol
CAS No.：14191-95-8
Formula：C8H7NO
MWt：133.15
€42,00 – €50,00
Catalog No：TA-Fr14438
Manufacturer：TargetMol
Synonyms：4-Methylbenzoic acid
CAS No.：99-94-5
Formula：C8H8O2
MWt：136.15
€43,00 – €97,00
Catalog No：TA-Fr14115
Manufacturer：TargetMol
CAS No.：98-55-5
Formula：C10H18O
MWt：154.3
€41,00 – €50,00
Catalog No：TA-Fr12339
Manufacturer：TargetMol
Synonyms：Anisylacetone
CAS No.：104-20-1
Formula：C11H14O2
MWt：178.2
€39,00 – €50,00